Filters close
Released: 21-Sep-2012 12:25 PM EDT
Mount Sinai Researchers Identify Predictors for Inpatient Pain
Mount Sinai Health System

Researchers from Mount Sinai School of Medicine have identified reliable predictors of pain by surveying patients throughout their hospital stays about the severity of their pain and their levels of satisfaction with how their pain was managed by hospital staff. Using this data, interdisciplinary teams treating patients were able to identify patients at higher risk for pain prior to, or immediately upon, their admission to the hospital, and create and implement intervention plans resulting in patients reporting lower levels of pain and higher levels of satisfaction with their pain management. The study is published online in the American Journal of Medical Quality.

Released: 20-Sep-2012 12:35 PM EDT
Mount Sinai School of Medicine Bringing Free Courses Online
Mount Sinai Health System

Mount Sinai School of Medicine has signed an agreement with Coursera.org that will make Mount Sinai graduate and medical school courses freely available online.

Released: 20-Sep-2012 9:30 AM EDT
Mount Sinai School of Medicine Researchers Awarded “Provocative Questions” Grant from National Cancer Institute
Mount Sinai Health System

Two Mount Sinai School of Medicine researchers are among a select group of scientists from around the world who have been recognized by the National Cancer Institute (NCI) for their quest to answer the most pressing questions about cancer.

10-Sep-2012 11:00 AM EDT
Researchers Reveal a Chemotherapy-Resistant Cancer Stem Cell as the “Achilles' Heel” of Cancer
Mount Sinai Health System

Scientists at Mount Sinai School of Medicine have discovered a subpopulation of cells that display cancer stem cell properties and resistance to chemotherapy, and participate in tumor progression. This breakthrough could lead to the development of new tests for early cancer diagnosis, prognostic tests, and innovative therapeutic strategies, as reported in Cancer Cell.

7-Sep-2012 2:00 PM EDT
Health Care Spending in Last Five Years of Life Exceeds Total Assets for One Quarter of Medicare Population
Mount Sinai Health System

As many as a quarter of Medicare recipients spend more than the total value of their assets on out-of-pocket health care expenses during the last five years of their lives, according to researchers at Mount Sinai School of Medicine. They found that 43 percent of Medicare recipients spend more than their total assets minus the value of their primary residences. The findings appear online in the current issue of the Journal of General Internal Medicine.

17-Aug-2012 2:45 PM EDT
Dual Action Polyclonal Antibody May Offer More Effective, Safer Protection Against Osteoporosis
Mount Sinai Health System

A new study suggests that a polyclonal antibody that blocks follicle-stimulating hormone (FSH) in mice without ovaries might offer a more effective way to prevent or arrest osteoporosis than currently available treatments.

Released: 20-Aug-2012 3:00 PM EDT
New Research in Mouse Model Finds a Specific Toxic Byproduct of Heat-Processed Food Leads to Increased Body Weight and Diabetes
Mount Sinai Health System

Researchers at Mount Sinai School of Medicine have identified a common compound in the modern diet that could play a major role in the development of abdominal obesity, insulin resistance, and type 2 diabetes.

Released: 13-Aug-2012 10:30 AM EDT
Rejected Drug May Protect Against Toxic Substance Common to Both Alzheimer’s and Parkinson’s Diseases
Mount Sinai Health System

Latrepirdine, which failed in U. S. Clinical trials of alzheimer’s disease, is showing new potential in an animal model.

Released: 13-Aug-2012 10:00 AM EDT
Researchers Identify New Drug Target for Schizophrenia
Mount Sinai Health System

Finding provides new drug development opportunity in this hard-to-treat disease.

Released: 3-Aug-2012 10:45 AM EDT
Aurka-to-p53 Signaling: A Link Between Stem Cell Regulation and Cancer
Mount Sinai Health System

Researchers at Mount Sinai School of Medicine, the University of Manchester, and the MD Anderson Cancer Center have found a new role for an oncogenic signaling pathway in embryonic stem cell (ESC) self-renewal and in reprogramming adult cells into an ESC-state, which will aid in the development of future cancer therapies.

30-Jul-2012 10:45 AM EDT
Rejected Alzheimer's Drug Shows New Potential in Animal Model
Mount Sinai Health System

An international team of scientists led by researchers at Mount Sinai School Medicine have discovered that a drug that had previously yielded conflicting results in clinical trials for Alzheimer’s disease effectively stopped the progression of memory deterioration and brain pathology in mouse models of early stage Alzheimer’s disease.

Released: 26-Jul-2012 10:00 AM EDT
Mount Sinai Researchers Present Outcomes of Robotic Surgery in Tobacco Users with Head and Neck Cancer at American Head and Neck Society Annual Meeting
Mount Sinai Health System

Predictors of disease severity in human papillomavirus-derived head and neck cancer, tobacco use, and the dramatic benefits of robotic surgery in people with head and neck cancer are among landmark research presented by Mount Sinai School of Medicine at the Eighth International Conference on Head and Neck Cancer.

Released: 25-Jul-2012 2:35 PM EDT
Mount Sinai Researchers Develop New Computational Method to Find Novel Connections from Gene to Gene, Drug to Drug and Between Scientists
Mount Sinai Health System

Researchers from Mount Sinai School of Medicine have developed a new computational method that will help organize scientific data, making it easier for scientists to identify and prioritize genes, drug targets, and connections between drugs.

2-Jul-2012 3:00 PM EDT
Researcher Finds Common Factors in Autism Spectrum Disorders, Schizophrenia, and Bipolar Disorder
Mount Sinai Health System

A team of researchers have found that schizophrenia or bipolar disorder seen in parents or siblings was associated with increased risk of autism spectrum disorder (ASD). The study was published online by Archives of General Psychiatry on Monday, July 2.

Released: 26-Jun-2012 4:15 PM EDT
Study Describes Symptoms and Severity of Fibromuscular Dysplasia (FMD)
Mount Sinai Health System

A patient registry is proving invaluable in cataloging the clinical features, symptoms, severity, and outcomes of fibromuscular dysplasia (FMD), a non-inflammatory vascular disease that can cause narrowing of arteries in the carotid (neck) and renal (kidney) arteries, which can result in headache, strokes, and aneurysms. Registry data revealed that 91 percent of patients are women diagnosed in the prime of their lives. As a result, physicians are developing best practices that can lead to early diagnosis and treatment with the goal of improved outcomes and fewer adverse vascular events.

Released: 26-Jun-2012 8:00 AM EDT
Simpler Lifestyle Found to Reduce Exposure to Endocrine Disrupting Chemicals
Mount Sinai Health System

A lifestyle that features fresh foods and limited use of products likely to contain environmental chemicals has been shown to reduce exposure to endocrine-disrupting chemicals (EDCs), such as BPA and phthalates, in a small population study. EDCs are linked to a number of adverse health complications including neuro-developmental delays, behavioral issues and fertility problems. They are produced by the millions of pounds per year and found extensively in a range of products that contain certain plastics.

Released: 25-Jun-2012 8:30 AM EDT
Mount Sinai Brings Benefit of Robotic Surgery to Sleep Apnea Sufferers
Mount Sinai Health System

The Center for Minimally Invasive and Robotic Surgery at The Mount Sinai Medical Center—a pioneer in robotic surgery—now offers the procedure to patients with sleep apnea, whose obstructive breathing prevents them from sleeping normally.

Released: 20-Jun-2012 3:55 PM EDT
New Delivery Method Improves Efficacy of Two Commonly-Prescribed Parkinson’s Disease Medications
Mount Sinai Health System

A new delivery method for levodopa/carbidopa, a common dual-drug Parkinson’s disease (PD) regimen, significantly improved the duration of the drugs’ effectiveness in people with advanced PD.

Released: 20-Jun-2012 9:00 AM EDT
Mount Sinai Is First Institution in New York State to Perform New Alzheimer’s Imaging Test on Patients in Clinical Setting
Mount Sinai Health System

The Mount Sinai Medical Center is the first institution in New York State to use in the clinical setting a newly approved imaging technique to detect Alzheimer’s disease (AD) in people who are cognitively impaired. Until now, physicians have been limited in their ability to diagnose AD, guided almost exclusively by a patient’s mental and behavioral symptoms and family history.

Released: 14-Jun-2012 1:30 PM EDT
Prostate Health Tips for Father’s Day from Dr. David Samadi of Mount Sinai School of Medicine
Mount Sinai Health System

David Samadi, MD, Vice-Chair of Urology at Mount Sinai School of Medicine, knows that many men put off caring for their health, even when they have a family. But just a loving nudge from his family can help keep Dad on track for long-term prostate health, prostate cancer prevention, and prostate cancer awareness.



close
0.16171